Eric Meier has over 25 years of experience in the health care market place specifically in the development and commercialization of novel disruptive and innovative health care solutions. These solutions span software, medical devices, drug delivery, and drug compounds. He has built world class teams with deep domain knowledge in the areas of behavioral health, neuroscience, oncology, cardiovascular, and general surgery. He has extensive experience in fund raising from a variety of US, European, and Asian sources including institutional, family office, strategic, and non-profit entities. He has raised over $200 million to date and structured a variety of complex transactions.
Mr. Meier has had extensive operating experience in both large and emerging companies.
At Johnson and Johnson, he led a variety of corporate development activities focused upon identifying new markets, technologies, and company prospects at several operating companies.
In 2000, Mr. Meier founded Calypso Medical and served as its President and CEO from 2000 - 2010, a medical device company providing real time tumor tracking company for the precise delivery of external beam radiation therapy. During that period, the company raised in excess of $175M, achieved five product clearances and treated in excess of 50,000 patients. In 2011, the company was acquired by Varian Medical Systems.
In 2010, Mr. Meier joined Cervel Neurotech, a medical device company providing targeted non-invasive deep brain stimulation for psychiatric and neurologic disorders, as President and CEO. Since 2010, Cervel has completed a variety of successful clinical studies including a randomized sham controlled study for patients suffering from depression. The company has built a world class management team and raised in excess of $25M.
Mr. Meier is a member of the board of directors of the Medical Device Manufacturers Association, Doernbecher Foundation, and Ziba Design.He is also an active angel investor.
Co-Founder & CEO, Nice Healthcare
Thompson Aderinkomi is currently co-founder and CEO of Nice Healthcare a technology enabled primary care clinic that delivers all care in the comfort of the patient's home and contracts directly with small employers. He also co-founded RetraceHealth in 2013 a direct primary care medical practice that went on to raise over $7 million. MN Governor Mark Dayton appointed Thompson to the inaugural board of directors for MNsure, the MN Health Insurance Exchange in April 2013. Finally, in 2013 Thompson co-founded Healthcare.mn the Twin Cities premier organization for healthcare entrepreneurs, which has grown to over 2,000 members. From the University of Minnesota, Thompson has earned a B.S. in Economics, an M.S. in Statistics and an MBA from the Carlson School of Management. He has been married for 17 years and has two young sons.
President & CEO, Thriveworks
Will, President and CEO at Thriveworks, started his career in finance and quickly found he had a passion for improving patient care delivery. He has spent his career dedicated to improving the patient experience and strongly believes the way to do that is by engaging the care teams that support the patient. Will has a belief that access to mental healthcare should be as fundamental as primary care and that Thriveworks is the best-positioned company to improve access for patients at scale.Prior to joining Thriveworks, Will worked in multisite healthcare services at Dartmouth, Sound Physicians, and Vein Clinics of America (VCA). Will has experience in high-growth, tech-enabled healthcare and was most recently the President and COO at VCA. Will completed an MBA from the Sloan School of Management at Massachusetts Institute of Technology (MIT), a Masters in Healthcare Delivery Science at Dartmouth College, and he was a Fellowship Scholar at the Dartmouth Institute for Health Policy and Clinical Practice. Will is also a guest lecturer in healthcare services at Cornell University.
GM, Platform, Thirty Madison
Julia F. Bernstein is GM, Platform at Thirty Madison, the virtual specialized care platform. An experienced executive in the digital health space, she has held leadership roles at Tempest, Beacon Health Options and Ginger.io. She also advises and invests in early stage startups, and serves on PharmaCCX’s Board of Directors. Julia holds a MBA from Stanford Graduate School of Business and am AB from Dartmouth College.